Depressive symptom profiles, cardio-metabolic risk and inflammation: Results from the MIDUS study

Diana A. Chirinos, Kyle Murdock, Angie S. LeRoy, Christopher Fagundes

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation. Methods Our sample was comprised of 1085 participants (55.80% female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined according to the Interim Joint Statement definition. CRP was used as a marker of inflammation. Results Four depressive symptom profiles were identified. The “No Symptoms” subgroup (60.65% of the sample) had the lowest overall scores across subscales. The “Mild Symptoms” subgroup (26.73%) was characterized by lower scores across indicators, with subscales measuring somatic symptoms being the highest within group. The “Moderate Symptoms” subgroup (10.32%) had higher scores across subscales (1 SD above the mean), with subscales measuring negative affect/loss of interest being the highest within group. Finally, the “Acute symptoms” subgroup (2.30%) was characterized by the highest overall scores (1.5–3 SD above the mean) on all indicators. After controlling for sociodemographic characteristics and health behaviors, the “Moderate Symptoms” subgroup was significantly associated with metabolic syndrome (OR = 1.595, p = 0.035) and obesity (OR = 1.555, p = 0.046). Further, there was a trend between the “Mild Symptoms” subgroup and the presence of obesity (OR = 1.345, p = 0.050). Inflammation attenuated these associations. Conclusions Four depressive symptom profiles were identified among healthy mid-life individuals in the US. These profiles are differentially associated with cardio-metabolic outcomes. Future work should examine whether distinct symptom profiles may reflect differential pathways to increased risk, and whether tailored management of symptoms is needed.

Original languageEnglish (US)
Pages (from-to)17-25
Number of pages9
JournalPsychoneuroendocrinology
Volume82
DOIs
StatePublished - Aug 1 2017

Fingerprint

Metabolome
Depression
Inflammation
Obesity
Health Behavior
Epidemiologic Studies
Sleep
Anxiety
Biomarkers

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Chirinos, Diana A. ; Murdock, Kyle ; LeRoy, Angie S. ; Fagundes, Christopher. / Depressive symptom profiles, cardio-metabolic risk and inflammation : Results from the MIDUS study. In: Psychoneuroendocrinology. 2017 ; Vol. 82. pp. 17-25.
@article{13b90893c0224461ac3f5c807f8fdd31,
title = "Depressive symptom profiles, cardio-metabolic risk and inflammation: Results from the MIDUS study",
abstract = "Background This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation. Methods Our sample was comprised of 1085 participants (55.80{\%} female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined according to the Interim Joint Statement definition. CRP was used as a marker of inflammation. Results Four depressive symptom profiles were identified. The “No Symptoms” subgroup (60.65{\%} of the sample) had the lowest overall scores across subscales. The “Mild Symptoms” subgroup (26.73{\%}) was characterized by lower scores across indicators, with subscales measuring somatic symptoms being the highest within group. The “Moderate Symptoms” subgroup (10.32{\%}) had higher scores across subscales (1 SD above the mean), with subscales measuring negative affect/loss of interest being the highest within group. Finally, the “Acute symptoms” subgroup (2.30{\%}) was characterized by the highest overall scores (1.5–3 SD above the mean) on all indicators. After controlling for sociodemographic characteristics and health behaviors, the “Moderate Symptoms” subgroup was significantly associated with metabolic syndrome (OR = 1.595, p = 0.035) and obesity (OR = 1.555, p = 0.046). Further, there was a trend between the “Mild Symptoms” subgroup and the presence of obesity (OR = 1.345, p = 0.050). Inflammation attenuated these associations. Conclusions Four depressive symptom profiles were identified among healthy mid-life individuals in the US. These profiles are differentially associated with cardio-metabolic outcomes. Future work should examine whether distinct symptom profiles may reflect differential pathways to increased risk, and whether tailored management of symptoms is needed.",
author = "Chirinos, {Diana A.} and Kyle Murdock and LeRoy, {Angie S.} and Christopher Fagundes",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.psyneuen.2017.04.011",
language = "English (US)",
volume = "82",
pages = "17--25",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",

}

Depressive symptom profiles, cardio-metabolic risk and inflammation : Results from the MIDUS study. / Chirinos, Diana A.; Murdock, Kyle; LeRoy, Angie S.; Fagundes, Christopher.

In: Psychoneuroendocrinology, Vol. 82, 01.08.2017, p. 17-25.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Depressive symptom profiles, cardio-metabolic risk and inflammation

T2 - Results from the MIDUS study

AU - Chirinos, Diana A.

AU - Murdock, Kyle

AU - LeRoy, Angie S.

AU - Fagundes, Christopher

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation. Methods Our sample was comprised of 1085 participants (55.80% female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined according to the Interim Joint Statement definition. CRP was used as a marker of inflammation. Results Four depressive symptom profiles were identified. The “No Symptoms” subgroup (60.65% of the sample) had the lowest overall scores across subscales. The “Mild Symptoms” subgroup (26.73%) was characterized by lower scores across indicators, with subscales measuring somatic symptoms being the highest within group. The “Moderate Symptoms” subgroup (10.32%) had higher scores across subscales (1 SD above the mean), with subscales measuring negative affect/loss of interest being the highest within group. Finally, the “Acute symptoms” subgroup (2.30%) was characterized by the highest overall scores (1.5–3 SD above the mean) on all indicators. After controlling for sociodemographic characteristics and health behaviors, the “Moderate Symptoms” subgroup was significantly associated with metabolic syndrome (OR = 1.595, p = 0.035) and obesity (OR = 1.555, p = 0.046). Further, there was a trend between the “Mild Symptoms” subgroup and the presence of obesity (OR = 1.345, p = 0.050). Inflammation attenuated these associations. Conclusions Four depressive symptom profiles were identified among healthy mid-life individuals in the US. These profiles are differentially associated with cardio-metabolic outcomes. Future work should examine whether distinct symptom profiles may reflect differential pathways to increased risk, and whether tailored management of symptoms is needed.

AB - Background This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation. Methods Our sample was comprised of 1085 participants (55.80% female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined according to the Interim Joint Statement definition. CRP was used as a marker of inflammation. Results Four depressive symptom profiles were identified. The “No Symptoms” subgroup (60.65% of the sample) had the lowest overall scores across subscales. The “Mild Symptoms” subgroup (26.73%) was characterized by lower scores across indicators, with subscales measuring somatic symptoms being the highest within group. The “Moderate Symptoms” subgroup (10.32%) had higher scores across subscales (1 SD above the mean), with subscales measuring negative affect/loss of interest being the highest within group. Finally, the “Acute symptoms” subgroup (2.30%) was characterized by the highest overall scores (1.5–3 SD above the mean) on all indicators. After controlling for sociodemographic characteristics and health behaviors, the “Moderate Symptoms” subgroup was significantly associated with metabolic syndrome (OR = 1.595, p = 0.035) and obesity (OR = 1.555, p = 0.046). Further, there was a trend between the “Mild Symptoms” subgroup and the presence of obesity (OR = 1.345, p = 0.050). Inflammation attenuated these associations. Conclusions Four depressive symptom profiles were identified among healthy mid-life individuals in the US. These profiles are differentially associated with cardio-metabolic outcomes. Future work should examine whether distinct symptom profiles may reflect differential pathways to increased risk, and whether tailored management of symptoms is needed.

UR - http://www.scopus.com/inward/record.url?scp=85018295013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018295013&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2017.04.011

DO - 10.1016/j.psyneuen.2017.04.011

M3 - Article

C2 - 28486177

AN - SCOPUS:85018295013

VL - 82

SP - 17

EP - 25

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

ER -